Eruption Of Skin — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for eruption of skin. 233 active patents protecting 9 drugs from 7+ originators. First major cliff: 2027. Daily refresh.

9
Approved drugs
233
Active US patents
64/100
Avg vulnerability
$2.9B
Annual revenue covered

Originators in Eruption Of Skin

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Teva Pharm 118 patents Merck & Co. 42 patents Mayne Pharma 38 patents Generic (originally Merck/Upjohn) 29 patents Eurofarma 4 patents Padagis Us 1 patents Taro 1 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating eruption of skin. Each bar = one year. Y-axis scaled to peak year (40 patents).

3
26
7
27
10
28
11
29
12
30
40
31
8
32
4
33
31
34
15
35
9
36
3
37
3
38
25
39
38
40
12
41

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Cutivate
FLUTICASONE PROPIONATE
 Teva Pharm 118 58 $69M 2026-08-26
Benzamycin
BENZOYL PEROXIDE
 Mayne Pharma 38 70 — 2028-02-03
Elocon
MOMETASONE FUROATE
 Merck & Co. 22 44 — 2026-11-29
Diprolene
BETAMETHASONE DIPROPIONATE
 Merck & Co. 20 62 — 2027-09-27
Decadron
dexamethasone
 Generic (originally Merck) 15 46 — 2027-12-19
Cortef
hydrocortisone
 Generic (originally Merck/Upjohn) 14 64 — 2032-11-19
Derma-Smoothe/Fs
FLUOCINOLONE ACETONIDE
 Eurofarma 4 72 — 2027-08-12
Verdeso
DESONIDE
 Padagis Us 1 80 $2.8B 2027-08-13
Topicort
DESOXIMETASONE
 Taro 1 83 — 2028-09-01

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
9849027 Derma-Smoothe/Fs method of use 88 2028-11-07
7998108 Derma-Smoothe/Fs method of use 83 2028-01-12
9868103 Benzamycin method of use 83 2028-08-08
12070629 Benzamycin method of use 81 2030-12-30
12083270 Cutivate method of use 81 2031-04-04
7500444 Cutivate other 80 2026-08-26
7500444 Cutivate other 80 2026-08-26
8460641 Verdeso method of use 80 2027-08-13
8277780 Topicort method of use 80 2028-09-01
9868103 Benzamycin method of use 75 2028-08-08

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
12303635 Elocon composition of matter 0 2039-04-08
10537585 Decadron formulation 25 2037-12-18
10159683 Decadron formulation 25 2034-05-23
10406332 Elocon formulation 25 2034-03-13
10799642 Decadron formulation 31 2032-05-11
8763222 Elocon formulation 31 2032-02-08
8409606 Decadron formulation 31 2030-05-14
11679210 Elocon formulation 33 2038-09-03
10376526 Elocon formulation 33 2034-09-04
9370483 Elocon formulation 33 2034-09-04

Related